NSE BSE
sandu pharmaceuticals ltd. stock

SANDU PHARMACEUTICALS LTD. Share Price

- - (%)
- NSE: SANDUPHQ

SANDU PHARMACEUTICALS LTD. Share Price Update

As of the latest trading session, SANDU PHARMACEUTICALS LTD. share price is currently at 60.37, which is down by -1.63 from its previous closing. Today, the stock has fluctuated between 59.83 and 61.98. Over the past year, SANDU PHARMACEUTICALS LTD. has achieved a return of 11.50 %. In the last month alone, the return has been 2.09 %. Read More...

SANDU PHARMACEUTICALS LTD. Performance

Day Range

Low59.83 High61.98
60.37

52 Week Range

Low 50.10 High 85.00
60.37

SANDU PHARMACEUTICALS LTD. Share Price

524703

SANDUPHQ

img img img img
No Data Available

Open Price

60.57

Prev. Close

62.01

Volume (Shares)

2760.00

Total traded value

1.66

Upper Circuit

.00

Lower Circuit

.00

Note: The current prices & values are delayed, Login to your account for live updates.

SANDU PHARMACEUTICALS LTD. Fundamentals


(Standalone)

Market Cap (Cr) 58.32
PE Ratio (TTM) 39.98
Book Value / Share 32.86
Beta 0.46
ROE 5.25%
EPS (TTM) 1.51
Dividend Yield 0.00%
Net Profit Qtr (Cr) 0.59

SANDU PHARMACEUTICALS LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars MAR 2024 (Values in Cr)
Revenue 15.60
Operating Expense 15.19
Net Profit 0.59
Net Profit Margin (%) 3.78
Earnings Per Share (EPS) 0.50
EBITDA 0.91
Effective Tax Rate (%) 16.66
Particulars DEC 2023 (Values in Cr)
Revenue 17.43
Operating Expense 17.08
Net Profit 0.21
Net Profit Margin (%) 1.20
Earnings Per Share (EPS) 0.21
EBITDA 0.54
Effective Tax Rate (%) 44.73
Particulars SEP 2023 (Values in Cr)
Revenue 16.61
Operating Expense 15.92
Net Profit 0.55
Net Profit Margin (%) 3.31
Earnings Per Share (EPS) 0.57
EBITDA 0.91
Effective Tax Rate (%) 27.27
Particulars JUN 2023 (Values in Cr)
Revenue 17.66
Operating Expense 17.44
Net Profit 0.11
Net Profit Margin (%) 0.62
Earnings Per Share (EPS) 0.11
EBITDA 0.35
Effective Tax Rate (%) 47.61
Particulars MAR 2023 (Values in Cr)
Revenue 15.26
Operating Expense 14.94
Net Profit 0.27
Net Profit Margin (%) 1.76
Earnings Per Share (EPS) 0.27
EBITDA 0.53
Effective Tax Rate (%) 26.31
Particulars MAR 2024 (Values in Cr)
Revenue 67.28
Operating Expense 65.63
Net Profit 1.46
Net Profit Margin (%) 2.17
Earnings Per Share (EPS) 1.51
EBITDA 2.71
Effective Tax Rate (%) 29.46
Particulars MAR 2023 (Values in Cr)
Revenue 65.35
Operating Expense 63.46
Net Profit 1.52
Net Profit Margin (%) 2.32
Earnings Per Share (EPS) 1.62
EBITDA 2.82
Effective Tax Rate (%) 31.53
Particulars MAR 2022 (Values in Cr)
Revenue 65.50
Operating Expense 63.26
Net Profit 1.59
Net Profit Margin (%) 2.42
Earnings Per Share (EPS) 1.99
EBITDA 2.96
Effective Tax Rate (%) 31.46
Particulars MAR 2021 (Values in Cr)
Revenue 58.76
Operating Expense 57.26
Net Profit 1.09
Net Profit Margin (%) 1.85
Earnings Per Share (EPS) 1.54
EBITDA 2.35
Effective Tax Rate (%) 35.11
Particulars MAR 2020 (Values in Cr)
Revenue 48.37
Operating Expense 47.89
Net Profit 0.72
Net Profit Margin (%) 1.48
Earnings Per Share (EPS) 1.02
EBITDA 1.90
Effective Tax Rate (%) 21.73
Particulars MAR 2023 (Values in Cr)
Book Value / Share 31.47
ROE % 5.00
ROCE % 7.57
Total Debt to Total Equity 0.00
EBITDA Margin 4.30
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 2.29
Total Assets 54.16
Total Liabilities 54.16
Total Equity 39.24
Share Outstanding 9660990
Price to Book Ratio 1.66
Return on Assets (%) 2.80
Return on Capital (%) 3.87
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 2.28
Total Assets 54.16
Total Liabilities 54.16
Total Equity 39.24
Share Outstanding 9660990
Price to Book Ratio 1.66
Return on Assets (%) 2.81
Return on Capital (%) 3.88
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 4.17
Total Assets 49.28
Total Liabilities 49.28
Total Equity 36.47
Share Outstanding 8810664
Price to Book Ratio 2.29
Return on Assets (%) 3.22
Return on Capital (%) 4.36
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 11.65
Total Assets 46.96
Total Liabilities 46.96
Total Equity 33.49
Share Outstanding 7920997
Price to Book Ratio 1.08
Return on Assets (%) 2.32
Return on Capital (%) 3.26
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 1.54
Total Assets 41.41
Total Liabilities 41.41
Total Equity 29.23
Share Outstanding 7081000
Price to Book Ratio 0.42
Return on Assets (%) 1.73
Return on Capital (%) 2.36
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 0.78
Total Assets 43.63
Total Liabilities 43.63
Total Equity 28.78
Share Outstanding 7081000
Price to Book Ratio 0.54
Return on Assets (%) 1.53
Return on Capital (%) 1.92
Particulars MAR 2023 (Values in Cr)
Net Income 2.21
Cash from Operations 0.92
Cash from Investing 0.53
Cash from Financing 0.57
Net change in Cash 1.33
Free Cash Flow 1.98
Particulars MAR 2023 (Values in Cr)
Net Income 2.22
Cash from Operations 0.92
Cash from Investing 0.52
Cash from Financing 0.57
Net change in Cash 1.32
Free Cash Flow 1.98
Particulars MAR 2022 (Values in Cr)
Net Income 2.31
Cash from Operations 1.82
Cash from Investing -5.47
Cash from Financing 0.93
Net change in Cash -3.58
Free Cash Flow 2.66
Particulars MAR 2021 (Values in Cr)
Net Income 1.68
Cash from Operations 8.04
Cash from Investing -5.57
Cash from Financing 1.29
Net change in Cash 3.31
Free Cash Flow 8.17
Particulars MAR 2020 (Values in Cr)
Net Income 0.91
Cash from Operations 6.34
Cash from Investing -0.36
Cash from Financing -5.35
Net change in Cash 0.47
Free Cash Flow 6.45
Particulars MAR 2019 (Values in Cr)
Net Income 1.01
Cash from Operations 4.05
Cash from Investing -0.10
Cash from Financing -4.25
Net change in Cash -0.61
Free Cash Flow 4.16
Company Name Price P/E P/B Market Cap 52 Week Low/High
SANDU PHARMACEUTICALS LTD. 60.37 39.98 1.83 58.32 50.10 / 85.00
BLISS GVS PHARMA LTD 110.15 12.05 1.19 1155.28 77.65 / 148.95
CIPLA LTD 1485.15 28.17 4.49 119928.54 1028.00 / 1581.70
FERMENTA BIOTECH LIMITED 229.35 0.00 2.33 675.00 137.10 / 262.00
GLAXOSMITHKLINE PHARMA LT 2570.70 66.32 24.49 43549.21 1376.50 / 2759.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
SANDU PHARMACEUTICALS LTD. 60.37 39.98 1.83 58.32 50.10 / 85.00
AMRUTAJAN HEALTH LTD 738.70 47.47 7.40 2135.63 556.05 / 826.00
ASTRAZENECA PHARMA IND LT 6349.65 106.48 22.29 15874.13 3730.00 / 7550.00
BLISS GVS PHARMA LTD 110.15 15.17 1.16 1155.28 77.65 / 148.95
ABBOTT INDIA LIMITED 27407.65 48.49 15.74 58241.26 21907.45 / 29628.15

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 61.40
  • 26 Days 60.60
  • 10 Days 61.30
  • 50 Days 60.50
  • 12 Days 61.20
  • 100 Days 62.60
  • 20 Days 60.70
  • 200 Days 72.80
62.00
PIVOT
First Resistance 63.00
Second Resistance 63.99
Third Resistance 64.99
First Support 61.01
Second Support 60.01
Third Support 59.02
RSI 57.93
MACD 0.54
Commodity Channel Index (CCI) 8.93
ADX 27.95
Williams % R -65.79

Over 1 Month

down

2.09

Over 3 Months

down

-1.01

Over 6 Months

down

-15.56

Over 1 Year

down

11.50

Over 3 Years

down

3.12

Over 5 Years

down

27.38

SANDU PHARMACEUTICALS LTD. Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

SANDU PHARMACEUTICALS LTD. Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
57.09
Promoter Holdings
42.9
FII
0.0
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Umesh Bhaskar Sandu Shareholding of Promoter and Promoter Group 1388693.0 14.37
Shashank Bhaskar Sandu Shareholding of Promoter and Promoter Group 1368755.0 14.17
Jayshree Bhaskar Sandu Shareholding of Promoter and Promoter Group 737000.0 7.63
Sanmark Realty And Finance Private Limited Public Shareholding 543930.0 5.63
Akshath Finvest And Properties Private Limited Shareholding of Promoter and Promoter Group 494182.0 5.12
Neelamber Leasing And Finvest Private Limited Public Shareholding 455495.0 4.71
Sanbro Marketing Services Pvt Ltd Public Shareholding 250000.0 2.59
Tanvi Jignesh Mehta Public Shareholding 232560.0 2.41
Noumura Realty And Constructions Private Limited Public Shareholding 219010.0 2.27
Phybrichem Engineers Private Limited Public Shareholding 155963.0 1.61
Hitesh Kuvelkar Public Shareholding 121427.0 1.26
Yogish Shetty Public Shareholding 103777.0 1.07
Trans Scan Securities Private Limited Public Shareholding 100000.0 1.04
Geeta U Sandu Shareholding of Promoter and Promoter Group 85000.0 0.88
Minal Shashank Sandu Shareholding of Promoter and Promoter Group 61100.0 0.63
Shubhada Prabhakar Sandu Shareholding of Promoter and Promoter Group 10000.0 0.1

SANDU PHARMACEUTICALS LTD.

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2023-09-18 0.75 Final 2023-09-19 Equity shares 2022-09-23 0.75 Final 2022-09-23 Equity shares 2021-09-22 0.5 Final 2021-09-24 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About SANDU PHARMACEUTICALS LTD.

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by SANDU PHARMACEUTICALS LTD.

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 5x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Sandu Pharmaceuticals Ltd?

Answer Field

The share price of Sandu Pharmaceuticals Ltd for NSE is ₹ 0.00 and for BSE is ₹ 60.37.

What is the Market Cap of Sandu Pharmaceuticals Ltd?

Answer Field

The market cap of Sandu Pharmaceuticals Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 58.30 Cr. as of now.

What is the 52 Week High and Low of Sandu Pharmaceuticals Ltd?

Answer Field

The 52 Week High and Low of Sandu Pharmaceuticals Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 85.00 and ₹ 50.10.

How to Buy Sandu Pharmaceuticals Ltd share?

Answer Field

You can trade in Sandu Pharmaceuticals Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Sandu Pharmaceuticals Ltd?

Answer Field

The 1 year returns on the stock has been 11.50%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7.5 Lacs+ Users

icon-with-text

4.3+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4300 Cr MTF Book

icon-with-text
loader